In addition, the CD34+ compartment of BM cells in MDS/AML-MRC contains both the clonotypic (malignant) as well as non-malignant (normal) HSPCs [73], and the fact that we used unfractionated bulk of CD34+ cells for RNA-seq represents bias that could influence our results. This evidence concerns the gene CD200 and acute myeloid leukemia.